Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.37 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.34 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.34 |
| ▸ | ADH1B | P00325 | 1/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | ADH4 | P08319 | 1/20 | 0.33 |
| ▸ | ADH7 | P40394 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13069624 | 1.00 | NAAA (0.47) | NAAAMAPTGPR84FDPSFFAR1 | |
| SCHEMBL1123429 | 1.00 | NAAA (0.47) | NAAAMAPTGPR84FDPSFFAR1 | |
| SCHEMBL13105852 | 0.91 | NAAA (0.40) | NAAAMAPTGPR84FDPSFFAR1 | |
| SCHEMBL9975653 | 0.90 | TSHR (0.41) | NAAAMAPTGPR84FDPSFFAR1 | |
| SCHEMBL11321426 | 0.88 | NAAA (0.47) | NAAAMAPTGPR84FDPSFFAR1 | |
| SCHEMBL527174 | 0.87 | NAAA (0.58) | NAAAGPR84LMNAPPARDMEN1 | |
| SCHEMBL37419 | 0.87 | NAAA (0.58) | NAAAGPR84LMNAPPARDMEN1 | |
| SCHEMBL10791564 | 0.87 | NAAA (0.58) | NAAAGPR84LMNAPPARDMEN1 | |
| SCHEMBL15486455 | 0.87 | NAAA (0.58) | NAAAGPR84LMNAPPARDMEN1 | |
| SCHEMBL5575642 | 0.87 | NAAA (0.58) | NAAAGPR84LMNAPPARDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120157562-A1 | UREA-URETHANE GELLANT COMPOSITIONS WITH CONTROLLED MOLECULAR WEIGHT AND METHODS OF PREPARATION | XEROX CORPORATION (US) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157562-A1 | UREA-URETHANE GELLANT COMPOSITIONS WITH CONTROLLED MOLECULAR WEIGHT AND METHODS OF PREPARATION | UGP2, PUF60, UBA7 | NAAA 891/4885MAPT 133/4885GPR84 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.